?3MZI6=_'5($=OGVV?*+
SYSTEM PROCESSING...
?3MZI6=_'5($=OGVV?*+
SYSTEM PROCESSING...
Posted: 2025-04-25 21:46:03 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-25 21:56:05 UTC
Verified By
Rollup News
A new JITC article highlights MARC, a novel modular chimeric antigen receptor, which enhances T cell-based cancer immunotherapies by preventing early T cell exhaustion and improving persistence.
MARC improves T cell-based cancer immunotherapies
MARC prevents early T cell exhaustion
MARC enhances T cell persistence